Jane Street’s Aptevo Therapeutics APVO Stock Holding History

Jane Street’s Portfolio APVO Stock Details APVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$3.1K	–	9336
2024 Q3	$3.1K	Buy	+1	New	+$4.6K	﹤0.01%	9426
2019 Q3	–	Hold	0	–	-$22K	–	5024
2019 Q2	–	Hold	0	–	–	–	5014
2018 Q3	–	Hold	0	–	-$94K	–	5043
2018 Q2	–	Hold	0	–	–	–	4743

Other funds holding APVO

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CFFP

Center for Financial Planning Southfied, Michigan $1.07B AUM 18.98% 1-Year Est. Return

Jane Street's APVO Position: Q4 2024 in Review

Jane Street sold out of Aptevo Therapeutics (APVO) in Q4 2024, closing a stake of 1 share — an estimated $3.1K sold.

Jane Street first reported a position in APVO in Q3 2024 and held it in 1 quarter. The position peaked at $3.1K in Q3 2024. 7 funds tracked by Wall St. Rank hold APVO as of Q4 2024.

Jane Street reported no remaining Aptevo Therapeutics position as of Q4 2024 after selling out during the quarter.
Jane Street sold 1 Aptevo Therapeutics share in Q4 2024, an estimated $3.1K.
Jane Street first reported a position in Aptevo Therapeutics in Q3 2024 and held it in 1 quarter.
Jane Street's Aptevo Therapeutics position peaked at $3.1K in Q3 2024.
7 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.